Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1990 Aug;27(8):488–495. doi: 10.1136/jmg.27.8.488

Exclusion testing in pregnancy for Huntington's disease.

A Tyler 1, O W Quarrell 1, L P Lazarou 1, A L Meredith 1, P S Harper 1
PMCID: PMC1017196  PMID: 2145437

Abstract

The results of DNA analysis are presented for a series of 90 couples, with one partner at 50% risk for Huntington's disease (HD), who were referred for exclusion testing in pregnancy over a three year period. Thirty-seven couples were studied in detail. The aims of the study were to evaluate attitudes towards prenatal testing, before pregnancy and afterwards, and the effectiveness of our counseling and methods of organising the service. Problems which could arise in relation to presymptomatic testing are documented. It is concluded that exclusion testing is a valuable form of prediction for some couples, particularly where family structure does not permit prediction for the person at risk. The need for intensive counselling was highlighted by the difficulties experienced by many couples in understanding how the test worked. Particular ethical and organisational problems may arise which require careful consideration beforehand and some recommendations are made. The proportion of couples who will continue to request exclusion testing as pre-symptomatic testing becomes more widely applicable remains unknown.

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berg K., Fletcher J. Ethical and legal aspects of predictive testing. Lancet. 1986 May 3;1(8488):1043–1043. doi: 10.1016/s0140-6736(86)91320-6. [DOI] [PubMed] [Google Scholar]
  2. Brock D. J., Mennie M., Curtis A., Millan F. A., Barron L., Raeburn J. A., Dinwoodie D., Holloway S., Crosbie A., Wright A. Predictive testing for Huntington's disease with linked DNA markers. Lancet. 1989 Aug 26;2(8661):463–466. doi: 10.1016/s0140-6736(89)92084-9. [DOI] [PubMed] [Google Scholar]
  3. Craufurd D. I., Harris R. Ethics of predictive testing for Huntington's chorea: the need for more information. Br Med J (Clin Res Ed) 1986 Jul 26;293(6541):249–251. doi: 10.1136/bmj.293.6541.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Donnai P., Charles N., Harris R. Attitudes of patients after "genetic" termination of pregnancy. Br Med J (Clin Res Ed) 1981 Feb 21;282(6264):621–622. doi: 10.1136/bmj.282.6264.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evers-Kiebooms G., Cassiman J. J., van den Berghe H. Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium. J Med Genet. 1987 May;24(5):275–279. doi: 10.1136/jmg.24.5.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fahy M., Robbins C., Bloch M., Turnell R. W., Hayden M. R. Different options for prenatal testing for Huntington's disease using DNA probes. J Med Genet. 1989 Jun;26(6):353–357. doi: 10.1136/jmg.26.6.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farrer L. A., Myers R. H., Cupples L. A., Conneally P. M. Considerations in using linkage analysis as a presymptomatic test for Huntington's disease. J Med Genet. 1988 Sep;25(9):577–588. doi: 10.1136/jmg.25.9.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Farrer L. A. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet. 1986 Jun;24(2):305–311. doi: 10.1002/ajmg.1320240211. [DOI] [PubMed] [Google Scholar]
  9. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  10. Harper P. S., Quarrell O. W., Youngman S. Huntington's disease: prediction and prevention. Philos Trans R Soc Lond B Biol Sci. 1988 Jun 15;319(1194):285–298. doi: 10.1098/rstb.1988.0050. [DOI] [PubMed] [Google Scholar]
  11. Harper P. S., Sarfarazi M. Genetic prediction and family structure in Huntington's chorea. Br Med J (Clin Res Ed) 1985 Jun 29;290(6486):1929–1931. doi: 10.1136/bmj.290.6486.1929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hayden M. R., Hewitt J., Kastelein J. J., Langlois S., Wilson R. D., Fox S., Hilbert C., Bloch M. First-trimester prenatal diagnosis for Huntington's disease with DNA probes. Lancet. 1987 Jun 6;1(8545):1284–1285. doi: 10.1016/s0140-6736(87)90542-3. [DOI] [PubMed] [Google Scholar]
  13. Hayden M. R., Robbins C., Allard D., Haines J., Fox S., Wasmuth J., Fahy M., Bloch M. Improved predictive testing for Huntington disease by using three linked DNA markers. Am J Hum Genet. 1988 Nov;43(5):689–694. [PMC free article] [PubMed] [Google Scholar]
  14. Kessler S., Field T., Worth L., Mosbarger H. Attitudes of persons at risk for Huntington disease toward predictive testing. Am J Med Genet. 1987 Feb;26(2):259–270. doi: 10.1002/ajmg.1320260204. [DOI] [PubMed] [Google Scholar]
  15. Lamport A. T. Presymptomatic testing for Huntington chorea: ethical and legal issues. Am J Med Genet. 1987 Feb;26(2):307–314. doi: 10.1002/ajmg.1320260208. [DOI] [PubMed] [Google Scholar]
  16. Markel D. S., Young A. B., Penney J. B. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet. 1987 Feb;26(2):295–305. doi: 10.1002/ajmg.1320260207. [DOI] [PubMed] [Google Scholar]
  17. Mastromauro C., Myers R. H., Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet. 1987 Feb;26(2):271–282. doi: 10.1002/ajmg.1320260205. [DOI] [PubMed] [Google Scholar]
  18. Meissen G. J., Berchek R. L. Intended use of predictive testing by those at risk for Huntington disease. Am J Med Genet. 1987 Feb;26(2):283–293. doi: 10.1002/ajmg.1320260206. [DOI] [PubMed] [Google Scholar]
  19. Meissen G. J., Myers R. H., Mastromauro C. A., Koroshetz W. J., Klinger K. W., Farrer L. A., Watkins P. A., Gusella J. F., Bird E. D., Martin J. B. Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med. 1988 Mar 3;318(9):535–542. doi: 10.1056/NEJM198803033180903. [DOI] [PubMed] [Google Scholar]
  20. Meredith A. L., Upadhyaya M., Harper P. S. Molecular genetics in clinical practice: evolution of a DNA diagnostic service. BMJ. 1988 Oct 1;297(6652):843–846. doi: 10.1136/bmj.297.6652.843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Millan F. A., Curtis A., Mennie M., Holloway S., Boxer M., Faed M. J., Crawford J. W., Liston W. A., Brock D. J. Prenatal exclusion testing for Huntington's disease: a problem of too much information. J Med Genet. 1989 Feb;26(2):83–85. doi: 10.1136/jmg.26.2.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morris M., Tyler A., Harper P. S. Adoption and genetic prediction for Huntington's disease. Lancet. 1988 Nov 5;2(8619):1069–1070. doi: 10.1016/s0140-6736(88)90078-5. [DOI] [PubMed] [Google Scholar]
  23. Quarrell O. W., Meredith A. L., Tyler A., Youngman S., Upadhyaya M., Harper P. S. Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet. 1987 Jun 6;1(8545):1281–1283. doi: 10.1016/s0140-6736(87)90541-1. [DOI] [PubMed] [Google Scholar]
  24. Tyler A., Harper P. S. Attitudes of subjects at risk and their relatives towards genetic counselling in Huntington's chorea. J Med Genet. 1983 Jun;20(3):179–188. doi: 10.1136/jmg.20.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES